Corcept Therapeutics

Menlo Park,  CA 
United States
  • Booth: 709

Corcept is a pharmaceutical company engaged in the discovery, development and commercialization of drugs that treat severe metabolic, oncologic and psychiatric disorders by modulating the effects of cortisol. The company’s first product, Korlym® (mifepristone) 300 mg Tablets has been approved by the FDA for the control of hyperglycemia associated with Cushing syndrome.

Exhibitor Webinar Now Available! 

Maximize Your ROI at EMBRAACE 2020